Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Appetite ; 167: 105622, 2021 12 01.
Article in English | MEDLINE | ID: mdl-34363900

ABSTRACT

Our daily food choices have a huge impact on the environment. However, most consumers are not aware of the environmental impact of food production and consumption. Since there is no valid and reliable measure of knowledge regarding food's environmental impact, a 16-item multiple-choice knowledge questionnaire was developed. An example item reads: "Which of the following meals is the most climate friendly?" - Organic beef burger, Organic salmon burger, Quinoa burger, Do not know. The knowledge questionnaire was tested in a Swiss and German consumer sample (total N = 1810) and meets standard psychometric criteria. It showed good internal consistency across the adult samples. Validity was supported by small to medium-sized positive correlations with constructs of environmental (e.g., environmental apathy) and food (e.g., perceived environmentally friendly food purchasing behavior) attitudes. By using a food buffet made of replica food items, it was shown that consumers with higher knowledge scores are better able to compose lunch menus with a lower environmental footprint. The new scale will help to identify potential areas of misconceptions in people's understanding of the environmental friendliness of foods and in what respect a lack of knowledge poses a barrier to behavioral change. It also enables research into the efficacy of educational measures such as campaigns and decision aids for sustainable food consumption.


Subject(s)
Choice Behavior , Food Preferences , Adult , Consumer Behavior , Environment , Health Knowledge, Attitudes, Practice , Humans , Meals , Surveys and Questionnaires
2.
Eur J Dermatol ; 18(3): 308-12, 2008.
Article in English | MEDLINE | ID: mdl-18474461

ABSTRACT

Our aim was to analyze the effectiveness of palliative total skin electron beam therapy (TSEBT) in the management of advanced cutaneous T-cell non-Hodgkin's lymphoma (CTCL). Eighteen patients (median age 59 years) with advanced and therapy-refractory CTCL in stages IIB-IV were treated with TSEBT for the first time. The most common histological subtype was Mycosis fungoides (72%). All patients suffered from lymphoma-associated symptoms. Median daily fractions of 1 Gy were administered up to a median total dose of 25 Gy. The median follow-up period was 11 months. Nine patients (50%) achieved a complete response and seven patients (39%) had a limited response. The actuarial one-year progression-free survival was 24%. Four patients (22%) had continuing remission over a median period of six months. Lymphoma associated symptoms were improved in 16 patients (89%). The median overall survival after receiving TSEBT was 12 months, resulting in an actuarial one-year overall survival of 48%. Treatment related acute effects (grade 1 or 2) were observed in all patients during radiation therapy. Transient grade 3 epitheliolyses developed in five patients (28%), late skin effects (grade 1 and 2) in 16 patients (89%), and hypohidrosis was seen in six patients (33%). We conclude that TSEBT is a very efficient and tolerable palliative treatment for patients with advanced CTCL.


Subject(s)
Lymphoma, T-Cell, Cutaneous/radiotherapy , Mycosis Fungoides/radiotherapy , Palliative Care/methods , Radiotherapy, High-Energy , Skin Neoplasms/radiotherapy , Adult , Aged , Electrons/adverse effects , Electrons/therapeutic use , Female , Humans , Kaplan-Meier Estimate , Lymphoma, Large-Cell, Anaplastic/pathology , Lymphoma, Large-Cell, Anaplastic/radiotherapy , Lymphoma, T-Cell, Cutaneous/pathology , Male , Middle Aged , Mycosis Fungoides/pathology , Neoplasm Staging , Radiotherapy Dosage , Radiotherapy, High-Energy/adverse effects , Radiotherapy, High-Energy/methods , Remission Induction , Retrospective Studies , Sezary Syndrome/pathology , Sezary Syndrome/radiotherapy , Skin Neoplasms/pathology , Survival Rate , Treatment Outcome , Whole-Body Irradiation/adverse effects , Whole-Body Irradiation/methods
3.
Eur J Dermatol ; 17(3): 229-33, 2007.
Article in English | MEDLINE | ID: mdl-17478386

ABSTRACT

Merkel cell carcinoma (MCC) is a rare malignant tumour of the skin with a tendency to rapid local progression, frequent spread to regional lymph nodes and distant metastases. We report results with radiotherapy in the treatment of MCC.Thirty-nine patients with histologically proven MCC were treated. Fifteen patients had stage I disease (12 primary, 3 recurrent tumours). Twenty-one patients had stage II disease (10 primary, 11 recurrent tumours). Thirty patients were treated with surgery and adjuvant radiotherapy. Six patients with inoperable disease received radiotherapy alone. Three patients in stage III with distant metastases were treated with palliative radiotherapy. For stage I patients, 3-year loco-regional control (LC), disease-specific survival (DSS) and overall survival (OS) rates were 90%, 100%, and 100%, respectively. For stage II patients, LC, DSS, and OS were 78%, 55%, and 29%, respectively. LC did not differ significantly between stage I and II patients. But, patients presented to radiotherapy directly after operation showed significantly improved LC compared to patients referred in recurrent situation (p = 0.039). Two of six inoperable patients treated with radiotherapy alone relapsed locally. In the current study, surgery and immediate adjuvant radiotherapy resulted in strong loco-regional control. Radiotherapy alone is suggested only in inoperable or metastatic MCC.


Subject(s)
Carcinoma, Merkel Cell/radiotherapy , Skin Neoplasms/radiotherapy , Aged , Aged, 80 and over , Carcinoma, Merkel Cell/mortality , Carcinoma, Merkel Cell/pathology , Carcinoma, Merkel Cell/surgery , Female , Humans , Kaplan-Meier Estimate , Lymphatic Metastasis/radiotherapy , Male , Middle Aged , Neoplasm Metastasis/radiotherapy , Neoplasm Recurrence, Local/prevention & control , Neoplasm Staging , Palliative Care , Radiotherapy, Adjuvant , Retrospective Studies , Skin Neoplasms/mortality , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Treatment Outcome
4.
Int J Radiat Oncol Biol Phys ; 67(5): 1381-8, 2007 Apr 01.
Article in English | MEDLINE | ID: mdl-17275208

ABSTRACT

PURPOSE: To evaluate local control and patterns of failure in patients treated with intraoperative electron beam radiotherapy (IOERT) after total mesorectal excision (TME), to appraise the effectiveness of intraoperative target definition. METHODS AND MATERIALS: We analyzed the outcome of 243 patients with rectal cancer treated with IOERT (median dose, 10 Gy) after TME. Eighty-eight patients received neoadjuvant and 122 patients adjuvant external beam radiotherapy (EBRT) (median dose, 41.4 Gy), and in 88% simultaneous chemotherapy was applied. Median follow-up was 59 months. RESULTS: Local failure was observed in 17 patients (7%), resulting in a 5-year local control rate of 92%. Only complete resection and absence of nodal involvement correlated positively with local control. Considering IOERT fields, seven infield recurrences were seen in the presacral space, resulting in a 5-year local control rate of 97%. The remaining local relapses were located as follows: retrovesical/retroprostatic (5), anastomotic site (2), promontorium (1), ileocecal (1), and perineal (1). CONCLUSION: Intraoperative electron beam radiotherapy as part of a multimodal treatment approach including TME is a highly effective regimen to prevent local failure. The presacral space remains the site of highest risk for local failure, but IOERT can decrease the percentage of relapses in this area.


Subject(s)
Electrons/therapeutic use , Neoplasm Recurrence, Local/prevention & control , Rectal Neoplasms/radiotherapy , Rectal Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Intraoperative Period , Male , Middle Aged , Neoadjuvant Therapy/methods , Radiotherapy, Adjuvant/methods , Treatment Failure
5.
Int J Radiat Oncol Biol Phys ; 66(4): 1143-51, 2006 Nov 15.
Article in English | MEDLINE | ID: mdl-16979835

ABSTRACT

BACKGROUND: We analyzed the long-term results of patients with locally advanced rectal cancer using a multimodal approach consisting of total mesorectal excision (TME), intraoperative electron-beam radiation therapy (IOERT), and pre- or postoperative chemoradiation (CRT). PATIENTS AND METHODS: Between 1991 and 2003, 210 patients with locally advanced rectal cancer (65 International Union Against Cancer [UICC] Stage II, 116 UICC Stage III, and 29 UICC Stage IV cancers) were treated with TME, IOERT, and preoperative or postoperative CHT. A total of 122 patients were treated postoperatively; 88 patients preoperatively. Preoperative or postoperative fluoropyrimidine-based CRT was applied in 93% of these patients. RESULTS: Median age was 61 years (range, 26-81). Median follow-up was 61 months. The 5-year actuarial overall survival (OS), disease-free survival (DFS), local control rate (LC), and distant relapse free survival (DRS) of all patients was 69%, 66%, 93%, and 67%, respectively. Multivariate analysis revealed that UICC stage and resection status were the most important independent prognostic factors for OS, DFS, and DRS. The resection status was the only significant factor for local control. T-stage, tumor localization, type of resection, and type of chemotherapy had no significant impact on OS, DFS, DRS, and LC. Acute and late complications > or =Grade 3 were seen in 17% and 13% of patients, respectively. CONCLUSION: Multimodality treatment with TME and IOERT boost in combination with moderate dose pre- or postoperative CRT is feasible and results in excellent long-term local control rates in patients with intermediate to high-risk locally advanced rectal cancer.


Subject(s)
Dose Fractionation, Radiation , Drug Therapy/mortality , Radiotherapy, High-Energy/mortality , Rectal Neoplasms/mortality , Rectal Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Combined Modality Therapy , Digestive System Surgical Procedures , Female , Germany/epidemiology , Humans , Intraoperative Care/statistics & numerical data , Longitudinal Studies , Male , Middle Aged , Sacrum , Survival Analysis , Survival Rate , Treatment Outcome
6.
Int J Radiat Oncol Biol Phys ; 65(3): 773-9, 2006 Jul 01.
Article in English | MEDLINE | ID: mdl-16682152

ABSTRACT

PURPOSE: This study assesses the long-term outcome of patients with retroperitoneal soft-tissue sarcomas treated by maximal resection in combination with intraoperative electron-beam therapy (IOERT) and postoperative external-beam radiotherapy. METHODS AND MATERIALS: From 1991 to 2004, 67 patients were treated with curative intent for primary (n = 26) or recurrent (n = 41) retroperitoneal soft-tissue sarcoma. All patients underwent maximal resection in combination with IOERT (mean dose, 15 Gy), 45 patients underwent additional postoperative EBRT, and 20 patients were previously irradiated. RESULTS: The 5-year actuarial overall survival (OS), disease-free survival, local control (LC), and freedom from metastatic disease of all patients was 64%, 28%, 40%, and 50%, respectively. The 5-year LC inside the IOERT field was 72%. For patients who completed IOERT and EBRT after R0-resection 5-year and 10-year OS was 80%, and 5-year and 10-year LC was 100%. Only 1 of the 21 patients after R0-resection and only 8 of 34 patients after R1-resection compared with 9 of 12 patients after R2-resection experienced inside IOERT-field relapse. Grade II or higher late complications were seen in 21% of the patients, but only 2 patients required surgical intervention because of late complications. CONCLUSION: In selected patients, IOERT results in excellent local control and survival, with acceptable morbidity.


Subject(s)
Neoplasm Recurrence, Local/radiotherapy , Retroperitoneal Neoplasms/radiotherapy , Sarcoma/radiotherapy , Adolescent , Adult , Aged , Aged, 80 and over , Combined Modality Therapy/methods , Disease-Free Survival , Female , Humans , Intraoperative Period , Male , Middle Aged , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/surgery , Radiotherapy Dosage , Retroperitoneal Neoplasms/mortality , Retroperitoneal Neoplasms/surgery , Retrospective Studies , Sarcoma/mortality , Sarcoma/surgery , Statistics, Nonparametric
7.
Int J Radiat Oncol Biol Phys ; 64(5): 1416-23, 2006 Apr 01.
Article in English | MEDLINE | ID: mdl-16413697

ABSTRACT

PURPOSE: To analyze long-term prognosis and morbidity after limb-sparing treatment of patients with extremity soft-tissue sarcoma, with intraoperative electron boost radiotherapy (IOERT) followed by a moderate dose of external beam radiotherapy (EBRT). METHODS AND MATERIALS: A total of 153 patients who were treated in a single center from 1991 to 2004 were evaluated. Median IOERT dose was 15 Gy, mean EBRT dose 43 Gy (range, 40-50.4 Gy) in conventional fractionation (1.8-2 Gy). Median duration of follow-up was 33 months. Acute toxicity was assessed with Common Toxicity Criteria; late toxic effects were scored according to European Organization for Research and Treatment of Cancer/Radiation Therapy Oncology Group criteria. RESULTS: Five-year overall survival and 5-year local control rates were 77% and 78%, respectively. Whereas tumor size, patient age, and EBRT dose did not significantly affect outcome, resection status and grading were significant for survival; resection status and IOERT dose were significant for local control. Extremity salvage until death or time of follow-up was achieved in 90% of our patients, 86% of whom showed excellent limb function without impairment in activities of daily life. Acute toxicity Grade 2-4 was observed in 23% and late toxicity Grade 2-4 in 17% of patients. CONCLUSIONS: Treatment with IOERT combined with moderate doses of external beam irradiation yields high local control and extremity preservation rates in resected extremity soft-tissue sarcoma.


Subject(s)
Extremities , Limb Salvage/methods , Sarcoma/radiotherapy , Sarcoma/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Electrons/therapeutic use , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/surgery , Radiotherapy/methods , Sarcoma/mortality , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...